- Home
- Publications
- Publication Search
- Publication Details
Title
Current development in adenoviral vectors for cancer immunotherapy
Authors
Keywords
oncolytic adenovirus, adeno-immunotherapy, combinatorial therapy, cellular therapy, immune checkpoint blockade
Journal
Molecular Therapy-Oncolytics
Volume 23, Issue -, Pages 571-581
Publisher
Elsevier BV
Online
2021-11-20
DOI
10.1016/j.omto.2021.11.014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
- (2021) Florian Kreppel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity
- (2021) Mary K. McKenna et al. MOLECULAR THERAPY
- Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1
- (2021) Riikka Havunen et al. Cells
- Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
- (2021) D. G. Roy et al. Nature Communications
- Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control
- (2021) Dafne C. A. Quixabeira et al. Frontiers in Immunology
- Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors
- (2021) Amanda Rosewell Shaw et al. Communications Biology
- Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments
- (2021) Yasuhiro Shirakawa et al. EUROPEAN JOURNAL OF CANCER
- Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
- (2021) Firas Hamdan et al. Journal for ImmunoTherapy of Cancer
- Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy
- (2021) Karita Peltonen et al. Cancers
- A phase I/II study combining a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus and nab-paclitaxel/gemcitabine chemotherapy in advanced pancreatic cancer: An interim report.
- (2020) Benjamin Leon Musher et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
- (2020) David Ruano et al. MOLECULAR THERAPY
- Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors
- (2020) Caroline E. Porter et al. MOLECULAR THERAPY
- Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy
- (2020) Hiroshi Tazawa et al. Cancers
- Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
- (2020) Hong-My Nguyen et al. Cells
- Phase I/II study to evaluate systemic durvalumab + intraperitoneal (IP) ONCOS-102 in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Interim phase I clinical and translational results.
- (2020) Dmitriy Zamarin et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased DSG2 plasmatic levels identified by transcriptomic-based secretome analysis is a potential prognostic biomarker in laryngeal carcinoma
- (2020) Sarah Santiloni Cury et al. ORAL ONCOLOGY
- Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?
- (2020) Selas T.F. Bots et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity
- (2020) Praveensingh B. Hajeri et al. Cancers
- Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
- (2020) Michela Guardascione et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors
- (2020) Sandra Irenaeus et al. CANCER GENE THERAPY
- Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
- (2020) June Kyu Hwang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adenovirus Vector–Induced IL-6 Promotes Leaky Adenoviral Gene Expression, Leading to Acute Hepatotoxicity
- (2020) Kahori Shimizu et al. JOURNAL OF IMMUNOLOGY
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- Systemic cancer therapy with engineered adenovirus that evades innate immunity
- (2020) Svetlana Atasheva et al. Science Translational Medicine
- ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
- (2020) Brian B Haines et al. Cancer Immunology Research
- PHASE I TRIAL OF ONCOLYTIC ADENOVIRUS-MEDIATED CYTOTOXIC AND INTERLEUKIN-12 GENE THERAPY FOR THE TREATMENT OF METASTATIC PANCREATIC CANCER
- (2020) Kenneth N. Barton et al. Molecular Therapy-Oncolytics
- Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment
- (2020) Norihiro Watanabe et al. MOLECULAR THERAPY
- Antitumor effect of a dual cancer-specific oncolytic adenovirus on prostate cancer PC-3 cells
- (2019) Chuan-xin Cui et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
- (2019) Jana de Sostoa et al. Journal for ImmunoTherapy of Cancer
- A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
- (2019) Jean-Pascal Machiels et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Virus-based Cytokine Expression to Improve Immune Activity in Brain and Solid Tumors
- (2019) Taylor M. Pearl et al. Molecular Therapy-Oncolytics
- Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
- (2019) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- (2019) Venkatesh Sivanandam et al. Molecular Therapy-Oncolytics
- Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site
- (2019) Alessandra Lopes et al. Journal for ImmunoTherapy of Cancer
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- 612PSPICE, a phase I study of enadenotucirev in combination with nivolumab in tumours of epithelial origin: Analysis of the metastatic colorectal cancer patients in the dose escalation phase
- (2019) M G Fakih et al. ANNALS OF ONCOLOGY
- Artificially cloaked viral nanovaccine for cancer immunotherapy
- (2019) Manlio Fusciello et al. Nature Communications
- Immunology of Adenoviral Vectors in Cancer Therapy
- (2019) Amanda Rosewell Shaw et al. Molecular Therapy-Methods & Clinical Development
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Development of Gene Therapeutics for Head and Neck Cancer in China: From Bench to Bedside
- (2018) Wei Guo et al. HUMAN GENE THERAPY
- Bispecific antibodies for cancer therapy: A review
- (2018) Anuradha Krishnamurthy et al. PHARMACOLOGY & THERAPEUTICS
- CARs versus BiTEs: A Comparison between T Cell–Redirection Strategies for Cancer Treatment
- (2018) Clare Y. Slaney et al. Cancer Discovery
- Improving CART-Cell Therapy of Solid Tumors with Oncolytic Virus–Driven Production of a Bispecific T-cell Engager
- (2018) Anna Wing et al. Cancer Immunology Research
- A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy
- (2018) Aleksei A. Stepanenko et al. GENE
- A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to cutaneous and uveal melanoma patients
- (2018) Margarita Garcia et al. HUMAN GENE THERAPY
- Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer
- (2018) Manh-Hung Do et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells
- (2018) Joshua D. Freedman et al. CANCER RESEARCH
- Immune Checkpoint Inhibitor Toxicity in 2018
- (2018) Douglas B. Johnson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer
- (2018) Rachael Mooney et al. Molecular Therapy-Oncolytics
- Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
- (2017) A. Schiza et al. Journal of Translational Medicine
- Gene therapy for human ovarian cancer cells using efficient expression of Fas gene combined with γδT cells
- (2017) Jiajing Lin et al. Molecular Medicine Reports
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
- (2017) Zong Sheng Guo et al. Frontiers in Immunology
- A novel monoclonal antibody targeting coxsackie virus and adenovirus receptor inhibits tumor growth in vivo
- (2017) Manabu Kawada et al. Scientific Reports
- Blinatumomab: First Global Approval
- (2015) Mark Sanford DRUGS
- Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers
- (2015) Valentina Hoyos et al. MOLECULAR THERAPY
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy
- (2015) Otto Hemminki et al. Oncotarget
- Oncolytic virus expressing RANTES and IL-15 enhances function of CAR-modified T cells in solid tumors
- (2015) Nobuhiro Nishio et al. OncoImmunology
- Armed Oncolytic Virus Enhances Immune Functions of Chimeric Antigen Receptor-Modified T Cells in Solid Tumors
- (2014) N. Nishio et al. CANCER RESEARCH
- Adenovirus Vectors for Gene Therapy, Vaccination and Cancer Gene Therapy
- (2014) William Wold et al. CURRENT GENE THERAPY
- Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
- (2014) Lisa Farzad et al. Molecular Therapy-Oncolytics
- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
- (2013) S O Freytag et al. GENE THERAPY
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
- (2013) P. Leone et al. JNCI-Journal of the National Cancer Institute
- AdCD40L—Crossing the Valley of Death?
- (2012) Gustav Ullenhag et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Helper-dependent adenoviral vectors for liver-directed gene therapy
- (2011) N. Brunetti-Pierri et al. HUMAN MOLECULAR GENETICS
- Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus
- (2010) Guidong Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Adenoviral Producer Cells
- (2010) Imre Kovesdi et al. Viruses-Basel
- Increased expression of Dsg2 in malignant skin carcinomas
- (2010) Donna Brennan et al. Cell Adhesion & Migration
- Large-Scale Production of High-Quality Helper-Dependent Adenoviral Vectors Using Adherent Cells in Cell Factories
- (2009) Masataka Suzuki et al. HUMAN GENE THERAPY
- Local AdCD40L Gene Therapy is Effective for Disseminated Murine Experimental Cancer by Breaking T-cell Tolerance and Inducing Tumor Cell Growth Inhibition
- (2009) Camilla Lindqvist et al. JOURNAL OF IMMUNOTHERAPY
- Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters
- (2009) Sergia Bortolanza et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation